🇺🇸 FDA
Patent

US 7435733

Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds

granted A61PA61P5/40

Quick answer

US patent 7435733 (Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P5/40